Shopping Cart
- Remove All
- Your shopping cart is currently empty
TH1217, a potent and selective inhibitor of dCTPase pyrophosphatase 1 (dCTPase), demonstrates an IC50 value of 47 nM. It amplifies the cytotoxic impact of cytidine analogues on leukemia cells and exhibits potential against COVID-19 by modulating SARS-CoV-2 interactors.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $302 | In Stock |
Description | TH1217, a potent and selective inhibitor of dCTPase pyrophosphatase 1 (dCTPase), demonstrates an IC50 value of 47 nM. It amplifies the cytotoxic impact of cytidine analogues on leukemia cells and exhibits potential against COVID-19 by modulating SARS-CoV-2 interactors. |
Targets&IC50 | TPase:47 nM (IC50) |
In vitro | TH1217 (compound 30) inhibits dCTPase, enhances aqueous solubility (>100 μM), and improves plasma stability in vitro (t4h=86%), with suitable mouse microsomal half-lives (109 minutes). TH1217 displays good cell permeability (8.66×10^-6/1.30×10^-3 cm/s) and CYP inhibition[1]. |
Alias | TH 1217 |
Molecular Weight | 491.09 |
Formula | C20H17BCl2N4O6 |
Cas No. | 1862212-48-3 |
Smiles | Cc1nc2c(c(Cl)c(Cl)cc2n1Cc1ccc(cc1)[B-]12OC(=O)C[N+]1(C)CC(=O)O2)[N+]([O-])=O |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 117 mg/mL (238.2 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.